Nov 8 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2019 Sep 30, 2018 Dec 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 168 mln 8 mln 172 mln
(+1903.4 pct) (-57.1 pct) (+1953.2 pct)
Operating loss 1.21 loss 947 mln loss 1.87
Recurring loss 1.22 loss 958 mln loss 1.87
Net loss 1.20 loss 940 mln loss 1.86
EPS loss 101.88 yen loss 94.71 yen loss 145.99 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T